Leukotriene D 4 enhances immunoglobulin production in CD40-activated human B lymphocytes

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 4, 2006, Pages 924-930

  Lamoureux, Josée ^a   Stankova, Jana ^a   Rola Pleszczynski, Marek ^a  

^a Faculty of Medicine   (Canada)

Author keywords

antibodies; B cells; cell surface molecules; IL 4; lipid mediators; receptor

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; LEUKOTRIENE D4; MESSENGER RNA; MONTELUKAST; PEPTIDOLEUKOTRIENE; CALCIUM; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR; MEMBRANE PROTEIN;

ALLERGY; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; FIBROBLAST; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; METABOLISM;

ANTIGENS, CD40; B-LYMPHOCYTES; CALCIUM; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; INTERLEUKIN-4; LEUKOTRIENE D4; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, LEUKOTRIENE; RNA, MESSENGER;

EID: 33646018582     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.12.1329     Document Type: Article

References (52)

1. Brink C., Dahlen S.-E., Drazen J., Evans J.F., Hay D.W.P., Nicosia S., et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55 (2003) 195-227
2. Nicosia S., Capra V., and Rovati G.E. Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 14 (2001) 3-19
3. Kanaoka Y., and Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 173 (2004) 1503-1510
4. 4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103 (2000) 757-768
5. Labat C., Ortiz J.L., Norel X., Gorenne I., Verley J., Abram T.S., et al. A second cysteinyl leukotriene receptor in human lung. J Pharmacol Exp Ther 263 (1992) 800-805
6. Lee T.H., Austen K.F., Corey E.J., and Drazen J.M. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci U S A 81 (1984) 4922-4925
7. Lynch K.R., O'Neill G.P., Liu Q., Im D.S., Sawyer N., Metters K.M., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 (1999) 789-793
8. Sarau H.M., Ames R.S., Chambers J., Ellis C., Elshourbagy N., Foley J.J., et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 56 (1999) 657-663
9. Maekawa A., Kanaoka Y., Lam B.K., and Austen K.F. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc Natl Acad Sci U S A 98 (2001) 2256-2261
10. Martin V., Sawyer N., Stocco R., Unett D., Lerner M.R., Abramovitz M., et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. Biochem Pharmacol 62 (2001) 1193-1200
11. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S., et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275 (2000) 30531-30536
12. Takasaki J., Kamohara M., Matsumoto M., Saito T., Sugimoto T., Ohishi T., et al. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor. Biochem Biophys Res Commun 274 (2000) 316-322
13. Nothacker H.P., Wang Z., Zhu Y., Reinscheid R.K., Lin S.H., and Civelli O. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol 58 (2000) 1601-1608
14. 2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 276 (2001) 47489-47495
15. Figueroa D., Borish L., Baramki D., Philip G., Austin C., and Evans J. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 33 (2003) 1380-1388
16. Thivierge M., Stankova J., and Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 167 (2001) 2855-2860
17. Lemiere C., Pelissier S., Tremblay C., Chaboilez S., Thivierge M., Stankova J., et al. Leukotrienes and isocyanate-induced asthma: a pilot study. Clin Exp Allergy 34 (2004) 1684-1689
18. Ohd J.F., Nielsen C.K., Campbell J., Landberg G., Lofberg H., and Sjolander A. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 124 (2003) 57-70
19. Mellor E.A., Maekawa A., Austen K.F., and Boyce J.A. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci U S A 98 (2001) 7964-7969
20. 4 and regulation of vascular and inflammatory responses. Am J Respir Crit Care Med 164 (2001) 2098-2101
21. Amrani Y., Moore P.E., Hoffman R., Shore S.A., and Panettieri Jr. R.A. Interferon-γ modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Am J Respir Crit Care Med 164 (2001) 2098-2101
22. Thivierge M., Doty M., Johnson J., Stankova J., and Rola-Pleszczynski M. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol 165 (2000) 5221-5226
23. 4. J Allergy Clin Immunol 111 (2003) 1032-1040
24. Law C.-L., and Clark E.A. Cell-cell interactions that regulate the development of B-lineage cells. Curr Opin Immunol 6 (1994) 238-247
25. Clark E.A., and Ledbetter J.A. How B and T cells talk to each other. Nature 367 (1994) 425-428
26. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., et al. The CD40 antigen and its ligand. Annu Rev Immunol 12 (1994) 881-922
27. Schonbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58 (2001) 4-43
28. Huo L., and Rothstein T.L. Receptor-specific induction of individual AP-1 components in B lymphocytes. J Immunol 154 (1995) 3300-3309
29. Choi M.S., Brines R.D., Holman M.J., and Klaus G.G. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1 (1994) 179-187
30. Rothe M., Sarma V., Dixit V.M., and Goeddel D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269 (1995) 1424-1427
31. Berberich I., Shu G.L., and Clark E.A. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol 153 (1994) 4357-4366
32. Francis D.A., Karras J.G., Ke X.Y., Sen R., and Rothstein T.L. Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol 7 (1995) 151-161
33. Karras J.G., Wang Z., Huo L., Frank D.A., and Rothstein T.L. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J Immunol 159 (1997) 4350-4355
34. Hanissian S.H., and Geha R.S. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6 (1997) 379-387
35. Bishop G.A., and Hostager B.S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Fact Rev 14 (2003) 297-309
36. van Kooten C., and Banchereau J. CD40-CD40 ligand. J Leukoc Biol 67 (2000) 2-17
37. Banchereau J., de Paoli P., Vallé A., Garcia E., and Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251 (1991) 70-72
38. Neron S., Pelletier A., Chevrier M.C., Monier G., Lemieux R., and Darveau A. Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand. Immunol Invest 25 (1996) 79-89
39. + B cell line. J Immunol 160 (1998) 2145-2157
40. Flores-Romo L., Foster D., Guy G.R., and Gordon J. Phorbol ester and calcium ionophore are sufficient to promote cell replication in cultures of quiescent human B lymphocytes. Immunology 66 (1989) 228-232
41. Rolfman C.M., Benedict S.H., Cheung R.K., and Gelfand E.W. Induction of human B cell proliferation and differentiation by the combination of phorbol ester and ionomycin. Eur J Immunol 17 (1987) 701-706
42. Holgate S.T., Peters-Golden M., Panettieri Jr. R.A., and Henderson W.R. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111 (2003) S18-S36
43. Dugas B., Paul-Eugene N., Cairns J., Gordon J., Calenda A., Mencia-Huerta J.M., et al. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4. J Immunol 145 (1990) 3406-3411
44. 4 enhances activation, proliferation, and differentiation of human B lymphocytes. J Immunol 143 (1989) 1996-2000
45. 4 enhances IL-4-induced IgE production from normal human lymphocytes. Cell Immunol 156 (1994) 124-134
46. Okunishi K., Dohi M., Nakagome K., Tanaka R., and Yamamoto K. A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol 173 (2004) 6393-6402
47. Sminia T., van der Brugge-Gamelkoorn G.J., and Jeurissen S.H. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol 9 (1989) 119-150
48. Dabak D.O., Aydin G., and Ozguner M. Dynamics of mast cells in lymph node following antigenic stimulation. Anat Histol Embryol 33 (2004) 5-10
49. Jabara H.H., Buckley R.H., Roberts J.L., Lefranc G., Loiselet J., Khalil G., et al. Role of JAK3 in CD40-mediated signaling. Blood 92 (1998) 2435-2440
50. Zarnegar B., He J.Q., Oganesyan G., Hoffmann A., Baltimore D., and Cheng G. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc Natl Acad Sci U S A 101 (2004) 8108-8113
51. Beinke S., and Ley S.C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 382 (2004) 393-409
52. Takeda K., Kishimoto T., and Akira S. STAT6: its role in interleukin 4-mediated biological functions. J Mol Med 75 (1997) 317-326